Latest News

STAT Plus: Pharmalittle: White House claims Dem pricing bill will yield 100 fewer drugs; trade deal may remove some biologic protections

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the squirrels are still gathering acorns and a warm breeze is emanating from the heating contraption. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation. Remember, no prescription is required. Meanwhile, here are a few items of interest. Have a grand day and drop us a line if you hear something saucy.

The White House claimed that the drug pricing bill pushed by House Democrats would result in as many as 100 fewer drugs hitting the U.S. market over the next decade, CNBC says. Citing an analysis from the Council of Economic Advisers, the White House also argued the bill would lead to worse health outcomes and cost the U.S. economy $1 trillion per year over that time period. The report suggests far greater consequences than other estimates for both the pharmaceutical industry and American consumers if the bill is enacted.

Continue to STAT Plus to read the full story…

Source link

Related posts

STAT Plus: Global Blood’s sickle cell disease drug heads to the FDA, but questions about patient benefit still linger


Radiation-Free Guidance for Vascular Catheters Using Smart Fiber Optics


Medical News Today: What can you do to reduce fibroid pain?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy